REVIEW article

Front. Endocrinol., 17 March 2023

Sec. Cellular Endocrinology

Volume 14 - 2023 | https://doi.org/10.3389/fendo.2023.1170023

Role of sphingolipid metabolites in the homeostasis of steroid hormones and the maintenance of testicular functions

  • 1. Fujian Provincial Key Laboratory of Reproductive Health Research, School of Medicine, Xiamen University, Xiamen, China

  • 2. Fujian Provincial Key Laboratory for Developmental Biology and Neurosciences, College of Life Sciences, Fujian Normal University, Fuzhou, China

Abstract

With the acceleration of life pace and the increase of work pressure, the problem of male infertility has become a social problem of general concern. Sphingolipids are important regulators of many cellular processes like cell differentiation and apoptosis, which are ubiquitously expressed in all mammalian cells. Various sphingolipid catabolic enzymes can generate multiple sphingolipids like sphingosine-1-phosphate and sphingomyelin. Present studies have already demonstrated the role of steroid hormones in the physiological processes of reproduction and development through hypothalamus-pituitary-gonad axis, while recent researches also found not only sphingolipids can modulate steroid hormone secretion, but also steroid hormones can control sphingolipid metabolites, indicating the role of sphingolipid metabolites in the homeostasis of steroid hormones. Furthermore, sphingolipid metabolites not only contribute to the regulation of gametogenesis, but also mediate damage-induced germ apoptosis, implying the role of sphingolipid metabolites in the maintenance of testicular functions. Together, sphingolipid metabolites are involved in impaired gonadal function and infertility in males, and further understanding of these bioactive sphingolipids will help us develop new therapeutics for male infertility in the future.

1 Introduction

Sphingolipids are a lipid family with a common sphingomyelin base skeleton, which participates in various physiopathological processes of cells, including steroid production, cell differentiation and apoptosis (–). In the mammalian reproductive system, many types of cells can produce sphingolipid metabolites, especially ceramide and sphingosine-1-phosphate, which are the second messengers (–). Therefore, sphingolipid metabolites in reproductive system have attracted much attention in recent years.

Steroid hormone is an important regulator of many physiological processes in mammalians (–). It is specifically synthesized in steroid-producing tissues through a series of multi-step reactions under the catalysis of monooxygenase and hydroxysteroid dehydrogenase superfamily members (–). It plays a very important regulatory role in maintaining testicular functions (–). Many sphingolipid metabolites can regulate the signaling pathways of steroid production, through acting as a second messenger in the signaling cascade to participate in the regulation of reproductive functions (, , , –).

Recent studies have shown that sphingolipid metabolites not only participate in the regulation of steroid biosynthesis (, , , , , , ), but also participate in the production of male sperm, and mediate the apoptosis of germ cells induced by stress or injury (, , , ), indicating that sphingolipids may be related to the impairment of gonadal function and infertility. In general, this research field provides an exciting direction for basic biology and clinical medicine, which can further study the possible role of abnormal sphingolipids in male infertility.

In the present review, we summarized the research progress on the role of sphingolipid metabolites in steroid hormone balance and testicular function maintenance during recent years, providing a theoretical basis to develop new therapies for male fertility.

2 Sphingolipid and its metabolites

Sphingolipids have always been considered as the structural inert component of the cell membrane with sphingomyelin base skeleton (–). Okazaki et al. found that in various types of cells, different stimuli can promote sphingomyelinase to split sphingomyelin, and then send signals (, ). Since sphingosine can inhibit PKC (–), people have generated great interest in sphingomyelin metabolites.

The biosynthesis of sphingolipids is from serine and palmitoyl CoA, and finally converted into ceramide, the precursor of all sphingolipids (). The process of sphingolipid metabolism includes two stages, de novo synthesis (Figure 1A) and following salvage (Figure 1B). More and more evidences show that sphingolipids, as a structural component of cell membrane, have a signaling transduction function (, , ), and the special membrane micro-region rich in cholesterol and sphingolipid is considered as the center of signal molecular organization, participating in the signaling transduction of G protein-coupled receptor and growth factor receptor (, , ). Therefore, sphingolipids are widely considered to play an important role in cell signaling at present.

Figure 1

At present, a variety of sphingolipid metabolites have been found and their physiological effects have also been clarified, such as glycosphingolipids (, , ). These molecules are similar in structure and can be transformed into each other, but their biological functions are different (, ). Given the low concentration of these sphingolipid metabolites, they may function as an important signaling molecules participating in various cell events, like cell cycle arrest, apoptosis and intercellular interaction, such as S1P and C1P (, ). C1P is the main metabolite of ceramide, which can inhibit cell apoptosis and induce cell survival (, , ), besides prostaglandin synthesis and arachidonic acid release (, , ). Like ceramide, SPH participates in apoptosis (, ) and also inhibits PKC (, ) and PLD (). Noteworthy, sphingolipid metabolites are being extensively studied as potential anticancer targets, since many intracellular and extracellular cytokine regulates the dynamic balance between sphingolipid metabolites through ceramidase, SK and S1P phosphatase (, , , , ).

3 Testicular synthesis of steroid hormones

The biosynthesis of steroid hormones is from cholesterol through the sequence activity of CYP and HSD, mainly occurring in tissues such as testis, ovary, adrenal gland and placenta (Figure 2) (, , , , , )

Figure 2

The main site of androgen biosynthesis is testis, and the expression of tissue-specific steroid gene is the reason for the difference of sex hormones (, , ). When the peptide hormone is combined with the homologous GPCR in the target tissue, the steroid biosynthesis is started, and then the steroid hormone is synthesized through the two different time stages of acute and chronic response stages, so as to ensure its secretion in an appropriate and controlled manner (, , ).

The acute response stage of steroid biosynthesis involves StAR activation. StAR can promote the rapid mobilization of cholesterol from the outer to the inner layer of mitochondrial membrane (–). Besides rate-limiting enzyme StAR, other proteins like PBR, HSL and SR-BI are also involved (, –).

The chronic response stage of steroid biosynthesis involves the transcription activation of steroid hormone genes. This process is mainly through activating various signaling like cAMP/PKA by adenylate cyclase for transcriptional activation (, ). SF-1 is one of the main transcription factors during this process, whose activity is regulated by phosphorylation and acetylation (, , ).

Many peptide hormones are involved in the initiation of steroidogenesis, such as FSH, LH and ACTH (, ). The combination of these peptide hormones to their homologous receptors leads to downstream signaling activation, mainly cAMP/PKA signaling, thus activating many target transcriptions (Figure 3) (, ). Besides cAMP/PKA, other signaling of cytokines and sphingolipids are also involved in regulating the synthesis of steroid hormones (). The biosynthesis of testicular hormones is closely related to the specific expression profiles of steroid hormone synthases, such as CYP11A1 and 3βHSD, which are expressed in testis ().

Figure 3

4 The role of sphingolipid metabolites in the synthesis of steroid hormones

Although cAMP/PKA is main signaling, studies have found that sphingolipids can be used as the second regulator of steroid biosynthesis (Figure 4) (, ). For example, ACTH/cAMP can reduce the number of sphingomyelin, ceramide and SPH in the cells, and increase S1P production through SK activation (). Bioactive sphingolipids can not only regulate the expression of CYP (), but also act as the ligand of SF-1 (, ). Therefore, sphingolipids have been identified as one important synthesis regulator.

Figure 4

4.1 Ceramide and steroid biosynthesis

Ceramide can regulate cytokine-mediated signaling, like TNF-α, FasL, INF-γ and IL-1β, leading to the changes in steroid biosynthesis (, , ). They regulates ceramide concentration through activating intracellular sphingomyelinases (, ), but the mechanism of ceramide functions still remains to be further studied.

In Leydig cells, TNF-α and IL-1β can not only activate sphingomyelinases and generate ceramide (), but also reduce StAR expression and testosterone secretion (), while ceramide can inhibit testosterone synthesis induced by hCG ().

Ceramide can also regulate the expression and activity of steroid synthases. For example, ceramide can regulate P450c17α expression and inhibit cAMP production (). Ceramide can also induce C/EBPβ recruitment to 11β-HSD1 promoter, thus activating gene expression ().

Lastly, ceramide metabolism enzymes also participate in steroid biosynthesis. For example, cortisol can increase sphingosine concentration through inducing N-acylsphingosine amidohydrolase 1 expression, leading to the inhibition of SF-1 functions during the regulation of steroid biosynthesis ().

4.2 Sphingosine and steroid biosynthesis

Sphingosine is also confirmed as a SF-1 ligand, since SF-1 binds to phospholipids (). Therefore, sphingosine is an antagonist of SF-1. Further investigation indicates that the combination of sphingosine with SF-1 leads to a decrease of CYP17 expression (). In addition, phosphatidic acid is the endogenous ligand of SF-1 (), since cAMP can promote phosphatidic acid binding to SF-1 and reverse sphingosine antagonism (Figure 4).

As SF-1 ligand, sphingosine adds another regulatory level of sphingomyelins during the synthesis of steroid hormones. Notably, sphingosine may regulate the process of development and sex differentiation through antagonizing SF-1, since SF-1 also regulates many related gene expressions during these processes (, , ).

4.3 Sphingosine-1-phosphate and steroid biosynthesis

S1P signaling is activated in and out of cells by binding to specific S1P receptors (). There are five S1P receptors, which combines with multiple heterotrimeric G proteins to activate specific intracellular targets, such as PI-3K, ERK and Rho (–).

The binding of S1P and its homologous receptor is the main signaling transduction, and PI-3K/Akt and ERK pathways are its downstream targets (, , ). The relationship between PI-3K/ERK activation and steroid biosynthesis further indicates the important role of S1P during the regulation of steroid biosynthesis (Figure 4) (, ).

4.4 Sphingomyelin and steroid biosynthesis

Sphingomyelin exists in cell membrane, which is the target of many external signals, involving in the regulation of steroid biosynthesis (, , ). Sphingomyelin can be hydrolyzed into ceramide by sphingomyelinases (), which is mediated by many stimulators, including TNF-α, IL-1β and FasL (, ). For example, S1P and C1P inhibit acid sphingomyelinase activity through the negative feedback loop of sphingomyelin metabolism pathway ().

In Leydig cells, sphingomyelin hydrolysis is associated with cholesterol migration (). In addition, lysosomal sphingomyelin can bind to SF-1 and cAMP can promote the separation of sphingomyelin from SF-1 (, ). Given the dynamic balance of different sphingolipid metabolites in specific cells, sphingomyelin play an important role in the regulation of steroid biosynthesis as a precursor of ceramide, lysosomal sphingomyelin and S1P ().

4.5 Glycosphingolipids and steroid biosynthesis

Bioactive sphingomyelins participate in steroid biosynthesis, however whether steroid hormones are involved in sphingolipid metabolism is another issue, which is exemplified in the neurosteroidogenesis between sphingomyelin and isoproterenone (, 54). Mellon et al. found that isoprenol treatment can reduce sphingomyelin and improve neurodegeneration (, 55). At the same time, sphingomyelin is critical for testosterone synthesis (, ), and testosterone can regulate the level of renal sphingomyelin (, ). Although the exact mechanism of molecular regulation is still unclear, these demonstrate the importance of sphingolipid metabolites and the complexity of steroid biosynthesis.

5 The role of sphingolipid metabolites in spermatogenesis

In mammals, testes are mainly composed of two functional regions, the seminiferous tubules containing germ cells and sertoli cells, and the stroma containing Leydig cells (, , 56). Among them, spermatogenesis is a complex physiological process, which mainly occurs in the seminiferous tubules and is regulated by the interaction between multiple hormones (FSH and LH) and cells (, , 57). The seminal vesicle contains many hydrolases, including sphingomyelinase, which is involved in sperm phospholipid hydrolysis, and closely related to sperm capacitation and fertilization (, , ).

Glycosphingolipids are widely expressed in cell membrane (58) and involved in differentiation, growth and transmembrane signaling (, ). For example, glycosphingolipids GM1 distributed in spermatozoa (59), and GM3 distributed in sertoli cells of seminiferous tubules (60). Analysis of sphingomyelin acyl composition of in ram sperm found that VLC PUFAs only bind with sphingomyelin, but not with other phospholipids ().

The study of fertile and sterile mice that block the biosynthesis of glycosphingolipids found that the synthesis of acidic subgroups of fucosylated glycosphingolipids was blocked in fertile and sterile mice, but the neutral subgroup of fucosylated glycosphingolipids was only missing in sterile mice (61). Glycosphingolipids not only play a role in the secretion of testosterone (62), but also is critical to the prolonged polarization of sperm and the stability of the sperm-sertoli cell contact ().

At the initial stage of spermatogenesis, not only fucosylated glycosphingolipids, but also ceramide and sphingomyelin (VLC-PUFA contents) firstly appear in the pachytene spermatocyte stage (63), and ceramide and sphingomyelin also appears in spermatocytes 25-27 days after birth (64), these compounds are the main components of mammalian sperm head (65).

During the last step of sperm maturation, ceramide and sphingomyelin also play a very important role in the sperm capacitation (), After sperm was treated with the agents of sperm capacitation, such as calcium, bicarbonate and albumin, sperm sphingomyelin was degraded to ceramide, which reduced the sphingomyelin/ceramide ratio several times (64). Therefore, the hydrolysis of sphingomyelin in sperm head may be the early biochemical change of sperm before fertilization (64), but the mechanism of its action in spermatogenesis and capacitation is still unclear and needs further research.

6 The role of sphingolipid metabolites in testicular cell apoptosis

Sphingolipid metabolites play not only an important role in spermatogenesis, but a regulatory role in apoptosis of germ cells after pathological stress of testis (, , , , , ).

Firstly, sphingomyelinase can inhibit gonadotropin-induced testosterone synthesis in Leydig cells, reduce the binding of gonadotropin to receptors, then decrease cAMP (, , ). In mammalian testis, Leydig cells can maintain spermatogenesis and androgen synthesis (, , , 57), indicating that sphingomyelinase not only reduces androgen synthesis, but also leads to excessive apoptosis of spermatogonia and spermatocytes.

Secondly, ceramide is involved in the process of testicular cell apoptosis mediated by various pathophysiological stresses. When male rats were treated with toxic compounds, their testicular cells were mostly Fas-positive and more sensitive to FasL (66). During the spermatogenesis, FasL/Fad is involved in the loss of germ cells (66, 67) and FasL can induce the increase of intracellular ceramide level (68). In testicular cells, Fas can activate cell apoptosis through ceramide signaling (69), indicating that Fas pathway is a sensor for toxic substances to induce testicular injury.

Thirdly, S1P may also participate in the apoptosis of testicular cells, since S1P can effectively inhibit chemotherapy-induced apoptosis of ovarian cells. Suomalainen et al. examined the changes of intracellular sphingolipids and cell apoptosis markers, and then found the elevated ceramide contents during the early apoptosis following with activated caspase 3 and appeared DNA laddering (70). Interestingly, reactive oxygen species inhibitor (n-acetyl-L-cysteine), not ceramide synthetase inhibitor (fumonisin B1) suppressed testicular apoptosis without ceramide changes, while S1P can inhibit testicular apoptosis by 30% (70). Additionally, ceramide-initiated SAPK/JNK signaling and protein phosphatase 2A activation is required during stress-induced apoptosis, such as TNF-a, FasL and X-rays (69–74).

Finally, ceramide is an important regulator of cell apoptosis (, , , , , , , 61), which may play a role through the following three mechanisms (Figure 5). (i) Instantaneous acid sphingomyelinase activation increases the membrane ceramide, promotes receptor aggregation and subsequent apoptosis signaling transduction. (ii) Ceramide is continuously produced through the activation of neutral sphingomyelinase or ceramide activated protein phosphatase, resulting in cell apoptosis. And (iii) plasma membrane phospholipid disorder occurs, presenting sphingomyelin to neutral sphingomyelinase, producing ceramide, and then forming the morphological changes of membrane vesicles and apoptosis.

Figure 5

At present, the role of ceramide in testicular cell apoptosis has made great progress, but the role of other sphingolipid metabolites during the apoptotic process of testicular cells remains to be further clarified.

7 Summary and prospect

Together, the contribution of sphingolipid metabolites to the homeostasis of steroid hormones and the maintenance of testicular functions is reviewed, but it is necessary to fully clarify their roles in male reproduction in the future. These bioactive sphingolipids, as key regulators, regulate steroid biosynthesis at different levels, including the expression and activity of steroid synthetases. In addition, sphingolipid metabolites participate in the regulation of male gametogenesis and testicular damage. However, the mechanism of these active molecules (such as ceramide and S1P) during male gonadal development and gametogenesis needs further study, and mass spectrometry, metabolomic analysis and proteomics are important tools to further study the physiological and pathological functions of sphingolipid metabolites. The present review about sphingolipid metabolites will help to formulate new strategies to improve gamete maturation and survival rate, thus optimizing various assisted reproductive technologies. In addition, the selective regulation of these active molecules in germ cells will help to protect the testis from chemotherapy damage, preserve the fertility of prognosis and improve the quality of life.

Statements

Author contributions

DW collected the literature and prepared the manuscript. YT collected the literature and made the illustrations. ZW conceptualized the article and revised the manuscript. All authors contributed to the article and approved the submitted version.

Funding

This work is supported by the Key Projects of Scientific and Technological Innovation in Fujian Province (2022G023), Fujian Provincial Natural Science Foundation (2020J01176 and 2022J01172), and the Innovation and Entrepreneurship Project of Fujian Normal University (I202102008).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Abbreviations

SPH, sphingosine; S1P, sphingomyelin-1-phosphate; PKC, protein kinase C; PKA, protein kinase A; cAMP, cyclic adenosine monophosphate; PLD, phospholipase D; SK, sphingosine kinase; StAR, steroidogenic acute regulatory protein; CYP, cytochrome P450; HSD, hydroxysteroid dehydrogenase; GPCR, G protein-coupled receptor; PBR, peripheral benzodiazepine receptor; HSL, hormone-sensitive lipase; SR-BI, class B type I scavenger receptor; SF-1, steroid forming factor-1; FSH, follicle stimulating hormone; LH, luteinizing hormone; ACTH, adreno corticotropic hormone; SK, sphingosine kinase; TNF-α, tumor necrosis factor-αγ FasL, Fas ligand; INF-γ, interferon-γγ IL-1β, interleukin-1βγ hCG, human gonadotropin; C/EBPβ, CCAAT/enhancer-binding protein-β; PI-3K, phosphatidylinositol 3-kinase; ERK, extracellular regulated kinase; VLC PUFAs, very long chain polyunsaturated fatty acids.

References

  • 1

    YangTZhaoJLiuFLiY. Lipid metabolism and endometrial receptivity. Hum Reprod Update (2022) 28:858–89. doi: 10.1093/humupd/dmac026

  • 2

    Hernandez-CoronadoCGGuzmanACastillo-JuarezHZamora-GutierrezDRosales-TorresAM. Sphingosine-1-phosphate (S1P) in ovarian physiology and disease. Ann Endocrinol (Paris) (2019) 80:263–72. doi: 10.1016/j.ando.2019.06.003

  • 3

    HuaGKolesnickR. Using ASMase knockout mice to model human diseases. Handb Exp Pharmacol (2013) 216:29–54. doi: 10.1007/978-3-7091-1511-4_2

  • 4

    AertsJMBootRGvan EijkMGroenerJBijlNLombardoEet al. Glycosphingolipids and insulin resistance. Adv Exp Med Biol (2011) 721:99–119. doi: 10.1007/978-1-4614-0650-1_7

  • 5

    LuckiNCSewerMB. Multiple roles for sphingolipids in steroid hormone biosynthesis. Subcell Biochem (2008) 49:387–412. doi: 10.1007/978-1-4020-8831-5_15

  • 6

    BhatOMYuanXLiGLeeRLiPL. Sphingolipids and redox signaling in renal regulation and chronic kidney diseases. Antioxid Redox Signal (2018) 28:1008–26. doi: 10.1089/ars.2017.7129

  • 7

    BoiniKMXiaMKokaSGehrTWLiPL. Sphingolipids in obesity and related complications. Front Biosci (Landmark Ed) (2017) 22:96–116. doi: 10.2741/4474

  • 8

    BoiniKMZhangCXiaMPoklisJLLiPL. Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet. J Pharmacol Exp Ther (2010) 334:839–46. doi: 10.1124/jpet.110.168815

  • 9

    JinSZhouFKatiraiFLiPL. Lipid raft redox signaling: molecular mechanisms in health and disease. Antioxid Redox Signal (2011) 15:1043–83. doi: 10.1089/ars.2010.3619

  • 10

    LiGKiddJGehrTWBLiPL. Podocyte sphingolipid signaling in nephrotic syndrome. Cell Physiol Biochem (2021) 55:13–34. doi: 10.33594/000000356

  • 11

    LiPLGulbinsE. Lipid rafts and redox signaling. Antioxid Redox Signal (2007) 9:1411–5. doi: 10.1089/ars.2007.1736

  • 12

    LiPLGulbinsE. Bioactive lipids and redox signaling: Molecular mechanism and disease pathogenesis. Antioxid Redox Signal (2018) 28:911–5. doi: 10.1089/ars.2017.7467

  • 13

    TillyJLKolesnickRN. Sphingolipids, apoptosis, cancer treatments and the ovary: Investigating a crime against female fertility. Biochim Biophys Acta (2002) 1585:135–8. doi: 10.1016/s1388-1981(02)00333-5

  • 14

    TillyJL. Commuting the death sentence: how oocytes strive to survive. Nat Rev Mol Cell Biol (2001) 2:838–48. doi: 10.1038/35099086

  • 15

    MoritaYTillyJL. Sphingolipid regulation of female gonadal cell apoptosis. Ann N Y Acad Sci (2000) 905:209–20. doi: 10.1111/j.1749-6632.2000.tb06551.x

  • 16

    OzbayTMerrillAHJr.SewerMB. ACTH regulates steroidogenic gene expression and cortisol biosynthesis in the human adrenal cortex via sphingolipid metabolism. Endocr Res (2004) 30:787–94. doi: 10.1081/erc-200044040

  • 17

    UrsANDammerESewerMB. Sphingosine regulates the transcription of CYP17 by binding to steroidogenic factor-1. Endocrinology (2006) 147:5249–58. doi: 10.1210/en.2006-0355

  • 18

    ZhangCLiPL. Membrane raft redox signalosomes in endothelial cells. Free Radic Res (2010) 44:831–42. doi: 10.3109/10715762.2010.485994

  • 19

    WalkerWHCookePS. Functions of steroid hormones in the male reproductive tract as revealed by mouse models. Int J Mol Sci (2023) 24:2748. doi: 10.3390/ijms24032748

  • 20

    DetlefsenAJPaulukinasRDPenningTM. Germline mutations in steroid metabolizing enzymes: a focus on steroid transforming aldo-keto reductases. Int J Mol Sci (2023) 24:1873. doi: 10.3390/ijms24031873

  • 21

    Naamneh ElzenatyRdu ToitTFluckCE. Basics of androgen synthesis and action. Best Pract Res Clin Endocrinol Metab (2022) 36:101665. doi: 10.1016/j.beem.2022.101665

  • 22

    ShahWKhanRShahBKhanADilSLiuWet al. The molecular mechanism of sex hormones on sertoli cell development and proliferation. Front Endocrinol (Lausanne) (2021) 12:648141. doi: 10.3389/fendo.2021.648141

  • 23

    XuRWangFZhangZZhangYTangYBiJet al. Diabetes-induced autophagy dysregulation engenders testicular impairment via oxidative stress. Oxid Med Cell Longev (2023) 2023:4365895. doi: 10.1155/2023/4365895

  • 24

    LiuWGongTShiFXuHChenX. Taste receptors affect male reproduction by influencing steroid synthesis. Front Cell Dev Biol (2022) 10:956981. doi: 10.3389/fcell.2022.956981

  • 25

    JiangJLiuSQiLWeiQShiF. Activation of ovarian taste receptors inhibits progesterone production potentially via NO/cGMP and apoptotic signaling. Endocrinology (2021) 162:bqaa240. doi: 10.1210/endocr/bqaa240

  • 26

    ShiZEnayatullahHLvZDaiHWeiQShenLet al. Freeze-dried royal jelly proteins enhanced the testicular development and spermatogenesis in pubescent male mice. Anim (Basel) (2019) 9:977. doi: 10.3390/ani9110977

  • 27

    TillyJLKolesnickRN. Sphingolipid signaling in gonadal development and function. Chem Phys Lipids (1999) 102:149–55. doi: 10.1016/s0009-3084(99)00083-3

  • 28

    KwakDHSeoBBChangKTChooYK. Roles of gangliosides in mouse embryogenesis and embryonic stem cell differentiation. Exp Mol Med (2011) 43:379–88. doi: 10.3858/emm.2011.43.7.048

  • 29

    SandhoffR. Very long chain sphingolipids: tissue expression, function and synthesis. FEBS Lett (2010) 584:1907–13. doi: 10.1016/j.febslet.2009.12.032

  • 30

    SpauldingSCBollagWB. The role of lipid second messengers in aldosterone synthesis and secretion. J Lipid Res (2022) 63:100191. doi: 10.1016/j.jlr.2022.100191

  • 31

    GoniFMSotJAlonsoA. Biophysical properties of sphingosine, ceramides and other simple sphingolipids. Biochem Soc Trans (2014) 42:1401–8. doi: 10.1042/BST20140159

  • 32

    GoniFMAlonsoA. Biophysics of sphingolipids i. membrane properties of sphingosine, ceramides and other simple sphingolipids. Biochim Biophys Acta (2006) 1758:1902–21. doi: 10.1016/j.bbamem.2006.09.011

  • 33

    MerrillAHJr.JonesDD. An update of the enzymology and regulation of sphingomyelin metabolism. Biochim Biophys Acta (1990) 1044:1–12. doi: 10.1016/0005-2760(90)90211-f

  • 34

    QiTLiLWeidongT. The role of sphingolipid metabolism in bone remodeling. Front Cell Dev Biol (2021) 9:752540. doi: 10.3389/fcell.2021.752540

  • 35

    LiuZYangHZhiLXueHLuZZhaoYet al. Sphingosine 1-phosphate stimulates insulin secretion and improves cell survival by blocking voltage-dependent k(+) channels in beta cells. Front Pharmacol (2021) 12:683674. doi: 10.3389/fphar.2021.683674

  • 36

    BodeCBerlinMRostelFTeichmannBGralerMH. Evaluating sphingosine and its analogues as potential alternatives for aggressive lymphoma treatment. Cell Physiol Biochem (2014) 34:1686–700. doi: 10.1159/000366370

  • 37

    DavisWJr. The ATP-binding cassette transporter-2 (ABCA2) overexpression modulates sphingosine levels and transcription of the amyloid precursor protein (APP) gene. Curr Alzheimer Res (2015) 12:847–59. doi: 10.2174/156720501209151019105834

  • 38

    HuwilerAKolterTPfeilschifterJSandhoffK. Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim Biophys Acta (2000) 1485:63–99. doi: 10.1016/s0009-3084(99)00071-7

  • 39

    SlotteJP. Sphingomyelin-cholesterol interactions in biological and model membranes. Chem Phys Lipids (1999) 102:13–27. doi: 10.1016/s0009-3084(99)00071-7

  • 40

    HungWCChangHCChuangLY. Activation of caspase-3-like proteases in apoptosis induced by sphingosine and other long-chain bases in Hep3B hepatoma cells. Biochem J (1999) 338(Pt 1):161–6. doi: 10.1042/bj3380161

  • 41

    NatarajanVJayaramHNScribnerWMGarciaJG. Activation of endothelial cell phospholipase d by sphingosine and sphingosine-1-phosphate. Am J Respir Cell Mol Biol (1994) 11:221–9. doi: 10.1165/ajrcmb.11.2.8049083

  • 42

    MillerWL. Mechanism of StAR's regulation of mitochondrial cholesterol import. Mol Cell Endocrinol (2007) 265-266:46–50. doi: 10.1016/j.mce.2006.12.002

  • 43

    SewerMBDammerEBJagarlapudiS. Transcriptional regulation of adrenocortical steroidogenic gene expression. Drug Metab Rev (2007) 39:371–88. doi: 10.1080/03602530701498828

  • 44

    HauetTLiuJLiHGazouliMCultyMPapadopoulosV. PBR, StAR, and PKA: partners in cholesterol transport in steroidogenic cells. Endocr Res (2002) 28:395–401. doi: 10.1081/erc-120016814

  • 45

    KraemerFBShenWJHaradaKPatelSOsugaJIshibashiSet al. Hormone-sensitive lipase is required for high-density lipoprotein cholesteryl ester-supported adrenal steroidogenesis. Mol Endocrinol (2004) 18:549–57. doi: 10.1210/me.2003-0179

  • 46

    LiuJRoneMBPapadopoulosV. Protein-protein interactions mediate mitochondrial cholesterol transport and steroid biosynthesis. J Biol Chem (2006) 281:38879–93. doi: 10.1074/jbc.M608820200

  • 47

    ParkerKLRiceDALalaDSIkedaYLuoXWongMet al. Steroidogenic factor 1: an essential mediator of endocrine development. Recent Prog Horm Res (2002) 57:19–36. doi: 10.1210/rp.57.1.19

  • 48

    JamesonJL. Molecular mechanisms of end-organ resistance. Growth Horm IGF Res (2004) 14 Suppl A:S45–50. doi: 10.1016/j.ghir.2004.03.012

  • 49

    MeroniSBPellizzariEHCanepaDFCigorragaSB. Possible involvement of ceramide in the regulation of rat leydig cell function. J Steroid Biochem Mol Biol (2000) 75:307–13. doi: 10.1016/s0960-0760(00)00188-6

  • 50

    MoralesVSantanaPDiazRTabraueCGallardoGLopez BlancoFet al. Intratesticular delivery of tumor necrosis factor-alpha and ceramide directly abrogates steroidogenic acute regulatory protein expression and leydig cell steroidogenesis in adult rats. Endocrinology (2003) 144:4763–72. doi: 10.1210/en.2003-0569

  • 51

    AraiNMasuzakiHTanakaTIshiiTYasueSKobayashiNet al. Ceramide and adenosine 5'-monophosphate-activated protein kinase are two novel regulators of 11beta-hydroxysteroid dehydrogenase type 1 expression and activity in cultured preadipocytes. Endocrinology (2007) 148:5268–77. doi: 10.1210/en.2007-0349

  • 52

    KiharaAMitsutakeSMizutaniYIgarashiY. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate. Prog Lipid Res (2007) 46:126–44. doi: 10.1016/j.plipres.2007.03.001

  • 53

    MellonSGongWGriffinLD. Niemann pick type c disease as a model for defects in neurosteroidogenesis. Endocr Res (2004) 30:727–35. doi: 10.1081/erc-200044016

  • 54

    GriffinLDGongWVerotLMellonSH. Niemann-pick type c disease involves disrupted neurosteroidogenesis and responds to allopregnanolone. Nat Med (2004) 10:704–11. doi: 10.1038/nm1073

  • 55

    MellonSH. Neurosteroid regulation of central nervous system development. Pharmacol Ther (2007) 116:107–24. doi: 10.1016/j.pharmthera.2007.04.011

  • 56

    MrukDDChengCY. Sertoli-sertoli and sertoli-germ cell interactions and their significance in germ cell movement in the seminiferous epithelium during spermatogenesis. Endocr Rev (2004) 25:747–806. doi: 10.1210/er.2003-0022

  • 57

    AkhtarMFAhmadEMustafaSChenZShiZShiF. Spermiogenesis, stages of seminiferous epithelium and variations in seminiferous tubules during active states of spermatogenesis in yangzhou goose ganders. Anim (Basel) (2020) 10:570. doi: 10.3390/ani10040570

  • 58

    KimSMKwakDHKimSMJungJULeeDHLeeSet al. Differential expression of gangliosides in the ovary and uterus of streptozotocin-induced and db/db diabetic mice. Arch Pharm Res (2006) 29:666–76. doi: 10.1007/BF02968251

  • 59

    TrevinoCLSerranoCJBeltranCFelixRDarszonA. Identification of mouse trp homologs and lipid rafts from spermatogenic cells and sperm. FEBS Lett (2001) 509:119–25. doi: 10.1016/s0014-5793(01)03134-9

  • 60

    JungKYKimBHHwangMRChoJRKimHMLeeYCet al. Differential distribution of ganglioside GM3 in seminiferous tubule and epididymis of adult rats. Arch Pharm Res (2001) 24:360–6. doi: 10.1007/BF02975107

  • 61

    SandhoffRGeyerRJennemannRParetCKissEYamashitaTet al. Novel class of glycosphingolipids involved in male fertility. J Biol Chem (2005) 280:27310–8. doi: 10.1074/jbc.M502775200

  • 62

    TakamiyaKYamamotoAFurukawaKZhaoJFukumotoSYamashiroSet al. Complex gangliosides are essential in spermatogenesis of mice: Possible roles in the transport of testosterone. Proc Natl Acad Sci USA (1998) 95:12147–52. doi: 10.1073/pnas.95.21.12147

  • 63

    RabionetMvan der SpoelACChuangCCvon Tumpling-RadostaBLitjensMBouwmeesterDet al. Male Germ cells require polyenoic sphingolipids with complex glycosylation for completion of meiosis: A link to ceramide synthase-3. J Biol Chem (2008) 283:13357–69. doi: 10.1074/jbc.M800870200

  • 64

    FurlandNEZanettiSROrestiGMMaldonadoENAveldanoMI. Ceramides and sphingomyelins with high proportions of very long-chain polyunsaturated fatty acids in mammalian germ cells. J Biol Chem (2007) 282:18141–50. doi: 10.1074/jbc.M700708200

  • 65

    FurlandNEOrestiGMAntolliniSSVenturinoAMaldonadoENAveldanoMI. Very long-chain polyunsaturated fatty acids are the major acyl groups of sphingomyelins and ceramides in the head of mammalian spermatozoa. J Biol Chem (2007) 282:18151–61. doi: 10.1074/jbc.M700709200

  • 66

    LeeJRichburgJHYounkinSCBoekelheideK. The fas system is a key regulator of germ cell apoptosis in the testis. Endocrinology (1997) 138:2081–8. doi: 10.1210/endo.138.5.5110

  • 67

    LeeDHKooDBKoKKoKKimSMJungJUet al. Effects of daunorubicin on ganglioside expression and neuronal differentiation of mouse embryonic stem cells. Biochem Biophys Res Commun (2007) 362:313–8. doi: 10.1016/j.bbrc.2007.07.142

  • 68

    SramekJNemcova-FurstovaVKovarJ. Molecular mechanisms of apoptosis induction and its regulation by fatty acids in pancreatic beta-cells. Int J Mol Sci (2021) 22:4285. doi: 10.3390/ijms22084285

  • 69

    VerheijMBoseRLinXHYaoBJarvisWDGrantSet al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature (1996) 380:75–9. doi: 10.1038/380075a0

  • 70

    SuomalainenLHakalaJKPentikäinenVOtalaMErkkiläKPentikäinenMOet al. Sphingosine-1-phosphate in inhibition of male germ cell apoptosis in the human testis. J Clin Endocrinol Metab (2003) 88:5572–9. doi: 10.1210/jc.2003-030776

  • 71

    BharathLPRuanTLiYRavindranAWanXNhanJKet al. Ceramide-initiated protein phosphatase 2A activation contributes to arterial dysfunction in vivo. Diabetes (2015) 64:3914–26. doi: 10.2337/db15-0244

  • 72

    KolesnickRGoldeDW. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell (1994) 77(3):325–8. doi: 10.1016/0092-8674(94)90147-3

  • 73

    Nikolova-KarakashianMNRozenovaKA. Ceramide in stress response. Adv Exp Med Bio (2010) 688:86–108. doi: 10.1007/978-1-4419-6741-1_6

  • 74

    OrsiniMChateauvieuxSRhimJGaigneauxACheillanDChristovCet al. Sphingolipid-mediated inflammatory signaling leading to autophagy inhibition converts erythropoiesis to myelopoiesis in human hematopoietic stem/progenitor cells. Cell Death Differ (2019) 26(9):1796–812. doi: 10.1038/s41418-018-0245-x

Summary

Keywords

steroid hormone, gametogenesis, sphingosine-1-phosphate, sphingomyelin, testicular function

Citation

Wang D, Tang Y and Wang Z (2023) Role of sphingolipid metabolites in the homeostasis of steroid hormones and the maintenance of testicular functions. Front. Endocrinol. 14:1170023. doi: 10.3389/fendo.2023.1170023

Received

20 February 2023

Accepted

07 March 2023

Published

17 March 2023

Volume

14 - 2023

Edited by

Guangbi Li, Virginia Commonwealth University, United States

Reviewed by

Fangxiong Shi, Nanjing Agricultural University, China; Genbao Shao, Jiangsu University, China; Yanqing Wu, Wenzhou University, China

Updates

Copyright

*Correspondence: Dr. Zhengchao Wang,

This article was submitted to Cellular Endocrinology, a section of the journal Frontiers in Endocrinology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics